Derivatives of 1,3,5-triamino-1,3,5-trideoxy-cis-inositol as versatile pentadentate ligands for protein labeling with Re-186/188. Prelabeling, biodistribution, and X-ray structural studies

Bioconjugate Chemistry

Volumn 9, Issue 6, 1998, Pages 691-702

  Kramer, Andreas ^a,b   Alberto, Roger ^b,c   Egli, André ^b   Novak Hofer, Ilse ^b   Hegetschweiler, Kaspar ^e   Abram, Ulrich ^d   Bernhardt, Paul V ^f   Schubiger, P August ^b  

^a ETH ZURICH   (Switzerland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; LIGANDS; POLYOLS; PROTEINS; SOLUTIONS; TIN COMPOUNDS;

% REDUCTIONS; BIODISTRIBUTIONS; CO-ORDINATION CHEMISTRIES; MONOCLINIC SPACE GROUPS; PENTADENTATE LIGANDS; PROTEIN LABELING; QUANTITATIVE YIELDS; SYNTHESISED; X-RAY STRUCTURAL STUDY; X-RAY STRUCTURE;

RHENIUM COMPOUNDS;

EID: 0032213896     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980014i     Document Type: Article

References (45)

1. Eary, J. F. (1991) Fundamentals of Radioimmunotherapy. Nucl. Med. Biol. 18, 105-108.
2. Pimm, M. V., and Baldwin, R. W. (1987) Comparative tumour localization properties of radiolabeled monoclonal antibody preparations of defined immunoreactivities. Eur. J. Nucl. Med. 13, 348-352.
3. Langmuir, V. K. (1992) Radioimmunotherapy: Clinical Results and Dosimetric Considerations. Nucl. Med. Biol. 19 (2), 213-225.
4. Hazra, D. K., Britton, K. E., Lahiri, V. L., Gupta, A. K., Khanna, P., and Saran, S. (1995) Immunotechnological Trends in Radioimmunotargeting: From Magic Bullet to Smart Bomb. Nucl. Med. Commun. 16, 66-75.
5. Srivastava, S. C., and Mease, R. (1991) Progress in Research on Ligands, Nuclides and Techniques for Labeling Monoclonal Antibodies. (1991) Nucl. Med. Biol. 18 (6), 589-603.
6. Schubiger, P. A., Alberto, R., and Smith, A. (1996) Vehicles, Chelators and Radionuclides: Choosing the Building Blocks of an Effective Radioimmunoconjugate. Bioconjugate Chem. 7, 165-179.
7. Cotton, F. A., and Wilkinson, G. (1980) Technetium and Rhenium. Advanced Inorganic Chemistry, 4th ed., pp 883-901, Wiley-Interscience, New York.
8. Deutsch, E., Libson, K., Vanderheyden, J.-L., Ketring, A., and Maxon, H. R. (1986) The Chemistry of Rhenium and Technetium as Related to the Use of Isotopes of these Elements in Therapeutic and Diagnostic Nuclear Medicine. Nucl. Med. Biol. 13, 465-477.
9. Jurisson, S., Berning, D., Jia, W., and Ma, D. (1993) Coordination Compounds in Nuclear Medicine. Chem. Rev. 93, 1137-1156.
10. 186Re Radioimmunotherapy of Small Cell Lung Carcinoma Xenografts in Nude Mice. Cancer Res. 51, 676-681.
11. Visser, G. W. M., Gerretsen, M., Herscheid, J. D. M., Snow, G. B., and van Dongen, G. (1993) Labeling of Monoclonal Antibodies with Rhenium-186 Using the MAG3 Chelate for Radioimmunotherapy of Cancer: A Technical Protocol. J. Nucl. Med. 34, 1953-1963.
12. Schroff, R. W., Weiden, P. L., Appelbaum, J., Fer, M. F., Breitz, H., Vanderheyden, J.-L., Ratliff, B., Fisher, D., Foisie, D., Hanelin, L. G., Morgan, A. C., Fritzberg, A. R., and Abrams, P. G. (1990) Rhenium-186 labeled antibody in patients with cancer: report on a pilot Phase I study. Antibody, Immunoconjugates, Radiopharm. 3, 99-110.
13. Breitz, H. B., Weiden, P. L., Vanderheyden, J.-L., Appelbaum, J. W., Bjorn, M. J., Mehmet, F. F., Wolf, S. B., Ratliff, B. A., Seiler, C. A., Foisie, D. C., Fisher, D. R., Schroff, R. W., Fritzberg, A. R., and Abrams, P. G. (1992) Clinical Experience with Rhenium-186 Labeled Monoclonal Antibodies for Radioimmuno-therapy: Results of Phase I Trials. J. Nucl. Med. 6, 1099-1112.
14. Li, M., and Meares, C. F. (1993) Synthesis, Metal Chelate Stability Studies, and Enzyme Digestion of Peptide Linked DOTA Derivative and its Corresponding Radiolabeled Immunoconjugates. Bioconjugate Chem. 4, 275-283.
15. DeNardo, S. J., Richman, C. M., Goldstein, D. S., Shen, S., Salako, Q., Kukis, D. L., Meares, C. F., Yuan, A., Welborn, J. L., and DeNardo, G. L. (1997) Yttrium-90/Indium-111 DOTA-Peptide-Chimeric L6-Pharmacokinetics, Dosimetry and Initial Results in Patients with Incurable Breast Cancer. Anticancer Res. 17, 1735-1744.
16. 111In-chelate Conjugated Anti-idiotype Monoclonal Antibody for Radioimmunodetection of Lymphoma in Mice. Eur. J. Nucl. Med. 12, 455-460.
17. Deshpande, S. V., DeNardo, S. J., Meares, C. F., McCall, M. J., Adams, G. P., and DeNardo, G. L. (1989) Effect of Different Linkage Between Chelates and Monoclonal Antibodies on Levels of Radioactivity in Liver. Nucl. Med. Biol. 16, 587-597.
18. 2 Chelate Ligands. Inorg. Chem. 33, 4850-4860.
19. Franklin, K. J., Howard-Lock, H. E., and Lock, C. J. L. (1982) Preparation, Spectroscopic Properties and Structure of 1-Oxo-2,3,6-(D-penicillaminato-N,S,O)-4,5-(D-penicillaminato-N,S)technetium(V). Inorg. Chem. 21, 1941-1946.
20. Buchegger, F., Haskell, C. M., Schreyer, M., Scazziga, B. R., Randin, S., Carrel, S., and Mach, J.-P. (1983) Radiolabeled Fragments of Monoclonal Antibodies against Carcinoembryonic Antigen for Localization of Human Colon Carcinoma Grafted into Nude Mice. J. Exp. Med. 158, 413-427.
21. 76Cu-labeled Intact and Fragmented Anti-Colon Carcinoma Monoclonal Antibody Mab35. Cancer Res. 53, 5727-5733.
22. 2 Fragments are More Efficient and Less Toxic Than Intact Anti-CEA Antibodies in Radioimmunotherapy of Large Human Colon Carcinoma Grafted in Nude Mice. J. Nucl. Med. 31, 1035-1044.
23. Humm, J. L. (1986) Dosimetric Aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med. 27, 1490-1497.
24. Yorke, E. D., Beaumier, P. L., Wessels, B. W., Fritzberg, A. R., and Morgan, A. C., Jr. (1991) Optimal Antibody-Radionuclide Combinations for Clinical Radioimmunotherapy: a Predictive Model Based on Mouse Pharmacokinetics. Nucl. Med. Biol. 18 (8), 827-835.
25. Smith, A., Alberto, R., and Schubiger, P. A. (1994) Influence of Radiolabel on the In Vivo Processing of Intact and Fragmented Anti-Tumour Monoclonal Antibody. J. Nucl. Biol. Med. 38 (Suppl. 1 to No. 4), 54-58.
26. Callahan, A. P., Rice, D. E., and Knapp, F. F., Jr. (1989) Re-188 for Therapeutic Applications from an Alumina Based W-188/Re-188 Radionuclide Generator System. NucCompact 20, 3-7.
27. Ghisletta, M., Jalett, H. P., Gerfin, T., Gramlich, V., and Hegetschweiler, K. (1992) 1,3,5-Triamino-1,3,5-trideoxy-cisinositol, a New Ligand with a Remarkable Versatility for Metal Ions. Part 2: Safe and Efficient Ligand Preparation and Structure of the Free Ligand and the Co(III) Complex. Helv. Chim. Acta 75, 2233-2242.
28. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. (1984) Determination of the Immuno-reactive Fraction of Radiolabeled Monoclonal Antibodies by Linear Extrapolation to Binding at Infinite Antigen Excess. J. Immunol. Methods 72, 77-89.
29. Sheldrick, G. M. SHELXL97 - A program for the refinement of X-ray crystal data, University of Göttingen, Germany 1997.
30. Hall, S. R., and Flack, H. D., Eds. The XTAL3.2 User's Manual, Universities of Western Australia, Geneva, and Maryland, 1992.
31. Sheldrick, G. M. SHELXS86 - A program for the solution of crystal structures, University of Göttingen, Germany 1986.
32. Sheldrick, G. M. SHELXL93 - A program for the refinement of crystal structures, University of Göttingen, Germany 1993.
33. Scattering factors, including f′ and f″, were taken from International Tables for Crystallography (1974) Vol. IV, Kynoch Press, Birmingham, England.
34. Bryson, N., Dewan, J. C., Lister-James, J., Jones, A. G., and Davison, A. (1988) Neutral Technetium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands. Inorg. Chem. 27, 2154-2161.
35. Davison, A., Jones, A. G., Orvig, C., and Sohn, M. (1981) A new class of Oxotechnetium(5+) Chelate complexes Containing a TcON2S2 Core. Inorg. Chem. 20, 1629-1632.
36. Brenner, D., Davison, A., Lister-James, J., and Jones, A. G. (1984) Synthesis and Characterization of a Series of Isomeric Oxotechnetium(V) Diamido Dithiolates. Inorg. Chem. 23, 3793-3797.
37. Fritzberg, A. R., Kasina, S., Eshima, D., and Johnson, D. L. (1986) Synthesis and Biological Evaluation of Technetium-99m MAG3 as a Hippuran Replacement. J. Nucl. Med. 27, 111-116.
38. Bläuenstein, P., Pfeiffer, G., Schubiger, P. A., Anderegg, G., Zollinger, K., May, K., Proso, Z., Ianovici, E., and Lerch, P. (1985) Chemical and Biological Properties of a Cationic Tc-Tetraamine Complex. Int. J. Appl. Radiat. Isot. 36 (4), 315-317.
39. Hegetschweiler, K., Egli, A., Alberto, R., and Schmalle, H. W. (1992) 1,3,5-Trideoxy-1,3,5-tris((2-hydroxybenzyl)amino)-cis-inositol, a Novel Multidentate Ligand Providing Various N,O-Coordination Sites. Structure of the Rhenium(V) Complex. Inorg Chem. 31, 4027-4028.
40. Hegetschweiler, K., Hancock, R. D., Ghisletta, M., Kradolfer, T., Gramlich, V., and Schmalle, H. W. (1993) 1,3,5-Triamino-1,3,5-trideoxy-cis-inositol, a Ligand with a Remarkable Versatility for Metal Ions. 5. Complex Formation with Magnesium(II), Calcium(II), Strontium(II), Barium(II), and Cadmium(II). Inorg. Chem. 32, 5273-5284.
41. Holloway, C. E., and Melnik, M. (1989) Rhenium coordination compounds: analysis and classification of crystallographic and structural data. Rev. Inorg. Chem. 10, 235 and references therein.
42. Cremer, D., and Pople, J. A. (1975) A General Definition of Ring Puckering Coordinates. J. Am. Chem. Soc. 97, 1354-1358.
43. Liang, C., Ewig, C. S., Stouch, T. R., Hagler, A. T. (1994) Ab initio studies of lipid model species. Conformational Analysis of Inositols. J. Am. Chem. Soc. 116, 3904-3911.
44. Connors, K. A. (1990) Chemical Cinetics, VCH Weinheim.
45. Smith-Jones, P. M., Fridrich, R., Kaden, A. T., Novak-Hofer, I., Siebold, K., Tschudin, D., and Mäcke, H. R. (1991) Antibody Labeling with Copper-67 Using the Bifunctional Macrocycle 4-[(1,4,8,11-Tetraazacyclotetradec-1-yl)methyl]-benzoic Acid. Bioconjugate Chem. 2, 415-421.